Table 2.
Health Characteristics of Participants that Completeda Measures for the UnProcessed Pantry Project, 2019 (n=37)
| Category | Baselinea | Posta | ||
|---|---|---|---|---|
| N(%) | Mean±SD | N(%) | Mean±SD | |
| Body Mass Index | 36.66±9.50 | 36.05±9.67* | ||
| Normal weight (18.5 to 24.99) |
2(5.4) | 3(8.1) | ||
| Overweight (25 to 29.99) |
9(24.3) | 8(21.6) | ||
| Obese (Greater than or equal to 30) |
26(70.3) | 26(70.3) | ||
| HbA1cb (%) | 5.88±1.18 | 5.91±1.00 | ||
| Normal (Less than 5.8) |
21(56.8) | 18(48.6) | ||
| Prediabetes (Greater than or equal to 5.7) |
9(24.3) | 12(32.4) | ||
| Diabetes (Greater than or equal to 6.5) |
7(18.9) | 7(18.9) | ||
|
Hypertension
(Systolicc / Diastolicd; mmHg) |
130.03±16.19 / 72.22±10.52 |
127.76±16.58 / 70.57±13.76 |
||
| Normal(Less than 120 and less than 80) | 11(29.7) | 10(27.0) | ||
| Elevated (120–129 and less than 80) |
5(13.5) | 8(21.6) | ||
| Hypertension Stage 1 (130–139 or 80–89) |
12(32.4) | 10(27.0) | ||
| Hypertension Stage 2 (140–179 or 90–119) |
9(24.3) | 8(21.6) | ||
| Hypertensive Crisis (Greater than or equal to 180 and/or greater than or equal to 120) |
0(0.0) | 1(2.7) | ||
| Cholesterol(mg/dL) | 200.95±43.98 | 192.03±41.55* | ||
| Desirable (Less than 200) |
18(48.6) | 24(64.9) | ||
| Borderline (200–239) |
14(37.8) | 8(21.6) | ||
| High Risk (Greater than or equal to 240) |
5(13.5) | 5(13.5) | ||
| Waist Circumference(inches) | 47.17±7.98 | 44.52±7.86* | ||
| Normal Risk ≤ 40 inches for men or 35 inches for women | 3(8.1) | 4(10.8) | ||
| Increased Risk > 40 inches for men or 35 inches for women | 34(91.9) | 33(89.2) | ||
| Food Insecure | -- | -- | ||
| No | 3(8.1) | 6(16.2) | ||
| Yes | 34(91.9) | 31(83.8) | ||
a
In total, 43 participants initially enrolled in the study and completed baseline measures (pre), 40 (93%) participants completed measures at 5 weeks (mid), and 37 (86%) completed measures at 15 weeks (post).
b
Due to instrumentation, clinically significant changes are observed at 0.05.
c
Due to instrumentation, clinically significant changes are observed at 10mmHG.
d
Due to instrumentation, clinically significant changes are observed at 5mmHG.
*
Significant differences detected when p < 0.05 from pre to post.
Original to this manuscript.